S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RGNX REGENXBIO Inc

8.29

0.00 (0.00%)

Pre Market

Last Updated: 06:00:51

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more REGENXBIO Charts.

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more REGENXBIO Charts.

REGENXBIO Inc News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 30 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

Apollo Global Management and Workday Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Friday 6 December 2024 (1 month ago) • PR Newswire (US)

REGENXBIO to Host Webcast Discussing Pivotal Program and First Functional Data from the AFFINITY DUCHENNE® Trial of RGX-202
Thursday 14 November 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

REGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational Updates
Wednesday 6 November 2024 (2 months ago) • PR Newswire (US)

REGENXBIO to Participate in Upcoming Investor Conferences
Monday 4 November 2024 (2 months ago) • PR Newswire (US)

More REGENXBIO Inc News Articles

Lightwave Logic

Bioelectronics (PK)

Moon Equity (PK)

North Bay Resources (PK)

Rennova Health (CE)

Kraig Biocraft Laborator... (QB)

GBT Technologies (PK)

TheGlobe com (PK)

Anavex Life Sciences

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Asia Broadband (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions